Work

Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias

Year: 2021

Type: article

Source: Nature Immunology

DOI: 10.1038/s41590-021-00895-4

Authors: Mahesh Raundhal, Shrestha Ghosh, Samuel A. Myers, Michael S. Cuoco, Meromit Singer, Steven A. Carr, Sushrut S. Waikar, Joseph V. Bonventre, Jerome Ritz, Richard M. Stone, David P. Steensma, Aviv Regev, Laurie H. Glimcher

Institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Broad Institute, Klarman Cell Observatory, Boston University, Boston Medical Center, Howard Hughes Medical Institute, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, U.S. Department of Health and Human Services, Dana-Farber Cancer Institute, Edward P. Evans Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1096292496, G1570399396, Novel Therapeutic Strategies in Human Myeloid Leukemias, G3209816816, Multi-faceted Roles of an Atypical Kinase RIOK2 in Erythropoiesis and Myelodyplastic Syndromes, G5219239052, Center of Excellence for High Throughput Proteogenomic Characterization, G5890648374, MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS, SPORE in Myeloid Malignancies, G8119746187, G9000240751

OpenAlex ID: W3135945997

FWCI: 2.077

Cites: 99

Cited by: 21

Related to: 10